Why Registry Clinical Trials Need ClinOne
DENVER, July 30, 2019 (Businesswire) – Given the length of the studies and large numbers of patients in these trials, clinical registries are typically quite costly. ClinOne continues to demonstrate its cost saving efforts through its proven far-reaching solutions.
Patient retention in registry studies proves challenging when there is seemingly limited benefit for patients, as compared to interventional studies. But the knowledge learned can be equally as valuable. ClinOne’s patient-facing technology facilitates patient engagement from the comfort of their own home. Data collection including ePRO questionnaires, dosing acknowledgement, and consenting can be completed remotely and limits the need for onsite visits.
ClinOne permits a BYOD (Bring Your Own Device) option, allowing patients to use their own devices – typically within arm’s reach on average up to 90% of their waking hours. Issuing devices to each patient every three years for a 10-year registry study is extraordinarily costly – including patient delivery, monthly support and actual device costs, as well as breakage or loss by the patients. BYOD being an option helps eliminate these extra expenses.
Patients can be consented remotely into low acuity registry studies through ClinOne’s technology, reducing the need for onsite study visits, increasing convenience and satisfaction to patients and their caregivers. Additionally, sponsors can electronically distribute important study updates, messages, and study results to patients and their families during their clinical research experience.
ClinOne offers a complete suite of mobile and web applications to enhance patient, family, caregiver and site engagement. Currently, our solutions help support nearly 3,000 clinical studies across 1,900 research sites in 55 countries. To learn more or to schedule a demo, please contact us. Visit www.clinone.com or email email@example.com for more information.